Global Transdermal Scopolamine Market to Reach $630.5 Million by 2030
The global market for Transdermal Scopolamine estimated at US$416.7 Million in the year 2022, is projected to reach a revised size of US$630.5 Million by 2030, growing at a CAGR of 5.3% over the analysis period 2022-2030.The U.S. Market is Estimated at $124.9 Million, While China is Forecast to Grow at 5% CAGR
The Transdermal Scopolamine market in the U.S. is estimated at US$124.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$110.7 Million by the year 2030 trailing a CAGR of 5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.Select Competitors (Total 41 Featured) -
- Alchem International
- Alkaloids of Australia
- ALZA Corporation
- Baxter International Inc.
- Caleb Pharmaceuticals Inc
- Centroflora-Cms
- Fine Chemicals Corporation
- GlaxoSmithKline Plc
- Myungmoon Pharma Co. Ltd.
- Novartis AG
- Perrigo Co. Plc
- Phytex Australia
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Alchem International
- Alkaloids of Australia
- ALZA Corporation
- Baxter International Inc.
- Caleb Pharmaceuticals Inc
- Centroflora-Cms
- Fine Chemicals Corporation
- GlaxoSmithKline Plc
- Myungmoon Pharma Co. Ltd.
- Novartis AG
- Perrigo Co. Plc
- Phytex Australia
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 194 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 416.7 Million |
Forecasted Market Value ( USD | $ 630.5 Million |
Compound Annual Growth Rate | 5.3% |
Regions Covered | Global |